TORONTO, ONTARIO -- (MARKET WIRE) -- May 18, 2007 -- PharmEng International Inc. ("PharmEng" or the "Company") (TSX VENTURE: PII) announced today that it has established a joint venture company in partnership with Beijing BRD Lixin PharmaTech Co. Ltd.("Lixin") of China to provide consulting and pharmaceutical development services in China. PharmEng will own 51% of the joint venture company, headquartered in Beijing, China and will operate under the name Beijing PharmEng BRD Lixin PharmaTech Consultation Co. Ltd.
